Catalyst Wire Dossier Catalyst Wire Dossier

CAIV-T (live attenuated influenza vaccine, trivalent)

live attenuated influenza vaccine, trivalent, cold-adapted · MedImmune LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAIV-T (live attenuated influenza vaccine, trivalent), covering 2009-04-10 to 2009-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers [Phase 3]

See pricing